Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion.
about
The cellular and molecular basis for malaria parasite invasion of the human red blood cellPlasmodium falciparum ring-infected erythrocyte surface antigen is released from merozoite dense granules after erythrocyte invasionIsotypic analysis of Plasmodium falciparum-specific antibodies and their relation to protection in Madagascar.All-D amino acid-containing channel-forming antibiotic peptides.Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues.Age-related buildup of humoral immunity against epitopes for rosette formation and agglutination in African areas of malaria endemicity.Sensitivity and specificity of isolated antigen fromPlasmodium falciparum culture supernatantSynthetic gene construct expressing a repeated and highly immunogenic epitope of the Plasmodium falciparum antigen Pf155.Structure of the RESA gene of Plasmodium falciparum.Anti-idiotypic antibodies counteract the invasion inhibition capacity of antibodies to major epitopes of the Plasmodium falciparum antigen Pf155/RESA.Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malariaRabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion.A Plasmodium falciparum antigen containing clusters of asparagine residues.Immunoglobulin response to Plasmodium falciparum RESA proteins in uncomplicated and severe malaria.Possible association of the Plasmodium falciparum T1526C resa2 gene mutation with severe malaria.Malaria vaccine development.Expression of the RESA gene in Plasmodium falciparum isolate FCR3 is prevented by a subtelomeric deletion.Antibodies to Pf155, a major antigen of Plasmodium falciparum: seroepidemiological studies in HaitiImmunogenicity and antigenicity in rabbits of a repeated sequence of Plasmodium falciparum antigen Pf155/RESA fused to two immunoglobulin G-binding domains of staphylococcal protein A.Affinity-purified antibodies to ring-infected erythrocyte surface antigen do not correlate with merozoite invasion inhibition in Plasmodium falciparum.Plasmodium chabaudi antigen Pch105, Plasmodium falciparum antigen Pf155, and erythrocyte band 3 share cross-reactive epitopesImmunological characteristics of malaria antibodies in two regions of Madagascar.Absence of antigenic diversity in Pf155, a major parasite antigen in membranes of erythrocytes infected with Plasmodium falciparumImmunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence.An update on candidate malaria vaccines.Membrane structure and function of malaria parasites and the infected erythrocyte.Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites.Involvement of Pf155/RESA and cross-reactive antigens in Plasmodium falciparum merozoite invasion in vitro.Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA.Antibodies to the ring-infected erythrocyte surface antigen of Plasmodium falciparum elicited by infection with Plasmodium malariae.Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys.Developments with anti-malarial vaccines.Epitope specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332.In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum.Human-human hybridomas secreting monoclonal antibodies to the Mr 195,000 Plasmodium falciparum blood stage antigen.Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettesAntibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.Isolation and expression of UB05, a Plasmodium falciparum antigen recognised by antibodies from semi-immune adults in a high transmission endemic area of the Cameroonian rainforest.Studies on glycoproteins in the human malaria parasite Plasmodium falciparum. Identification of a myristilated 45kDa merozoite membrane glycoprotein.Inhibition of in vitro growth of plasmodium falciparum field isolates mediated by human antibodies to Pf155/RESA and Pf332.
P2860
Q21032502-4808F4ED-1FAA-4E93-8357-C6FBC2D16BD5Q27972728-F3386113-6F2D-46DD-8E1C-E847F3750BA0Q33612549-9D070343-7855-47B3-9178-14002ED2B82BQ33643488-16865F11-EEBA-47DA-B421-E7897D1B677EQ33755404-6F8C1467-16A8-47D0-86E5-FCD7BDBFAD37Q33765361-A8088268-75D6-4A68-A2D0-7C7993BB6C07Q34459106-17FB9C7C-4746-4F9A-A8A1-9BAA9B6BE599Q34602484-AF56C49D-207E-43BE-91EB-EC4DDBEF5BD5Q35055418-1CCD78A8-B4A2-4C9B-80CD-1671DC2FB4BBQ35103469-2263B428-9680-4760-9275-0750DBC1DCC9Q35386488-7EB05BA2-5866-4584-9308-96A1994BC9F7Q35590960-0EDCD483-287E-4FE6-AAD6-1D486DCD0EDDQ35600722-2CE48F84-D396-4199-AFD7-DE22966BF17AQ35852373-7852CDC0-B75F-4D02-A46F-FF1C9AF7975AQ36173275-6077CBAA-3596-4CE6-BFD3-1E4A2799DB97Q36641624-13BF42C9-D3FB-4853-947A-4C4444F23FCAQ36759610-E67D228E-5581-46B0-A160-761B4F972D57Q36799341-086F44E3-D3A4-4D98-AA77-14CD14797126Q36978970-8A676544-3DC4-4F58-9077-6201583A4168Q36993849-04D9CAB1-B5D2-4C34-B312-15AA2F7ACA0BQ36996812-00F93824-7AA0-4CB5-8395-90DBE84DD94DQ37141041-A626FF48-306C-4AB4-B541-A1A1C71C467FQ37223728-2F8F1C12-DDAE-4E11-A39A-CC390661A86FQ38293658-854506E2-AA71-4780-AADE-A862F1619DCCQ38635546-CA4E300B-132A-472A-B910-91944FA3B74DQ39413188-52435414-9DCB-4608-908A-1526B07C1598Q40147908-988617CA-FFC2-410C-8C33-29D76D29E259Q40149203-2B5A6525-DFD3-4727-9126-3508123A0A4CQ40150313-6EA21AA2-4FAA-43B3-8D6F-75F2733B4795Q40157751-05AFAA60-C3B7-41CF-B00F-087ACE5E3311Q40171693-3AEFD65A-7093-4129-BFC2-64DDA5C70DE1Q40715913-DABE036D-521C-40C7-9159-E17F3774E06EQ41546168-236E186F-F05C-4F19-AF01-37F3FD96E259Q41915290-254DEFBC-ACC0-4F76-AEEE-ED9D85126B52Q42005028-E9D2501C-E877-4E95-B95F-E2657CF43EB8Q42573749-08321FF7-BB31-4F33-B35B-E9E4EA20DADEQ42938913-0644393B-93E9-4653-BA41-2C5195A4F45BQ43281332-A4FC7CE7-40FF-4866-9363-9C18058DB526Q43468469-D33D4324-99D1-48B1-B8CA-4483C44E31F4Q43935070-0786CDD5-FA09-4146-BFE1-8C1C507B024B
P2860
Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1984
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human antibodies to a Mr 155,0 ...... ly inhibit merozoite invasion.
@en
Human antibodies to a Mr 155,0 ...... ly inhibit merozoite invasion.
@nl
type
label
Human antibodies to a Mr 155,0 ...... ly inhibit merozoite invasion.
@en
Human antibodies to a Mr 155,0 ...... ly inhibit merozoite invasion.
@nl
prefLabel
Human antibodies to a Mr 155,0 ...... ly inhibit merozoite invasion.
@en
Human antibodies to a Mr 155,0 ...... ly inhibit merozoite invasion.
@nl
P2093
P2860
P356
P1476
Human antibodies to a Mr 155,0 ...... ly inhibit merozoite invasion.
@en
P2093
Björkman A
Patarroyo ME
Perlmann H
P2860
P304
P356
10.1073/PNAS.81.24.7912
P407
P577
1984-12-01T00:00:00Z